Barely Significant
← all excerpts

The Efficacy and Safety of Apatinib and Anlotinib in Advanced Non-Small Cell Lung Cancer.

Onco Targets Ther · 2024 · PMC11316477 · PMID 39131903

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

did not reach statistical significanceP > 0.05actually significant
Our study revealed that, in terms of short-term efficacy, apatinib demonstrated notable performance in ORR, while anlotinib was more effective in DCR; however, these differences did not reach statistical significance (P > 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.